Approval · Notice of Compliance 32012 · 2023
NUCEIVA: Notice of Compliance 32012
Issued November 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32012
- Date
- November 1, 2023
- Company
- Evolus IncorporatedNewport Beach, California, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph and package insert update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUCEIVA | Not yet assigned | — |
Medicinal ingredients
- PRABOTULINUMTOXINA 100 UNIT per VIAL